# FXYD7

## Overview
FXYD7 is a gene that encodes the FXYD domain containing ion transport regulator 7, a protein that is part of the FXYD family known for modulating ion transport across cell membranes. This protein is characterized as a type I transmembrane protein, featuring a conserved FXYD motif and two critical glycine residues within its transmembrane domain. FXYD7 is predominantly expressed in the brain, where it interacts with specific isoforms of the Na,K-ATPase enzyme, playing a crucial role in regulating ion gradients essential for neuronal excitability and signaling. By modulating the enzyme's affinity for potassium ions, FXYD7 influences cellular homeostasis and neuronal function (Garty2006ROLE; Crambert2004FXYD7). The protein's structure and post-translational modifications, such as O-glycosylation, are vital for its stability and function, highlighting its significance in maintaining proper ion transport processes in the brain (Geering2005Function; Crambert2004FXYD7).

## Structure
FXYD7 is a member of the FXYD protein family, characterized by a conserved FXYD motif and two conserved glycine residues in its transmembrane domain. The primary structure of FXYD7 includes an N-terminal extracellular domain, a single transmembrane domain, and a C-terminal intracellular domain (Geering2005Function; Crambert2004FXYD7). The transmembrane domain is crucial for its association with Na,K-ATPase, particularly involving the conserved glycine residues Gly 29 and Gly 40, which are essential for its function and stability (Crambert2004FXYD7).

The secondary structure of FXYD7 likely involves an alpha helix in the transmembrane region, as suggested by the helical wheel projection showing conserved residues on one face of the helix (Garty2006ROLE). The tertiary structure is stabilized by interactions within the transmembrane region, although specific details are not well-documented.

FXYD7 undergoes post-translational modifications, including O-glycosylation at the N-terminus, which contributes to its stability and prevents degradation (Crambert2004FXYD7). The C-terminal valine residue is critical for rapid export from the endoplasmic reticulum, influencing its post-translational association with Na,K-ATPase (Geering2005Function; Crambert2004FXYD7).

## Function
The FXYD7 gene encodes a brain-specific protein that is part of the FXYD protein family, which modulates the activity of the Na,K-ATPase enzyme. This enzyme is crucial for maintaining the electrochemical gradients of sodium and potassium ions across the plasma membrane, essential for cellular homeostasis. FXYD7 specifically interacts with the α1-β1 and α2-β1 isoforms of Na,K-ATPase, decreasing their apparent potassium affinity without affecting sodium affinity (Garty2006ROLE; Crambert2004FXYD7). 

FXYD7 is a type I membrane protein with an extracellular N-terminus, a transmembrane domain, and a cytoplasmic C-terminus. The transmembrane domain contains conserved glycine residues critical for its association with Na,K-ATPase, influencing the enzyme's transport properties (Crambert2004FXYD7). The protein is expressed in neurons and glial cells, suggesting a role in modulating neuronal excitability and signaling by affecting ion homeostasis in the brain (Garty2006ROLE). 

The intracellular domain of FXYD7 contains an ER export signal, crucial for its rapid export from the endoplasmic reticulum and subsequent association with Na,K-ATPase, highlighting its role in cellular ion transport processes (Crambert2004FXYD7).

## Clinical Significance
Mutations and alterations in the FXYD7 gene can have significant clinical implications due to its role in regulating Na,K-ATPase activity, which is crucial for maintaining ion balance in cells. Mutations in the transmembrane domain of FXYD7, such as the replacement of Glycine 40 with Arginine (G40R), completely abolish its association with Na,K-ATPase. This disruption can potentially lead to conditions related to ion imbalance, similar to the autosomal dominant renal hypomagnesaemia observed with a similar mutation in FXYD2 (Crambert2004FXYD7). Other mutations, like G40A and G40W, also reduce the association efficiency with Na,K-ATPase and affect the enzyme's apparent K+ affinity, which could impact cellular ion homeostasis (Crambert2004FXYD7).

Alterations in FXYD7 expression or its interactions may contribute to neurological disorders, given its exclusive expression in the brain and its role in modulating neuronal excitability (Geering2005Function). While specific diseases directly linked to FXYD7 mutations are not detailed, the disruption of its normal function could theoretically contribute to neurological conditions due to its critical role in maintaining proper neuronal function (Crambert2004FXYD7).

## Interactions
FXYD7 is a brain-specific protein that interacts with the Na,K-ATPase enzyme, a crucial component for maintaining ion gradients across the plasma membrane. FXYD7 specifically associates with the α1-β1 and α2-β1 isozymes of Na,K-ATPase, but not with the α3-β1 isozyme. This interaction leads to a decrease in the apparent affinity for extracellular K+ ions, which is significant for neuronal excitability (Garty2006ROLE; Geering2005Function; Crambert2004FXYD7).

The interaction between FXYD7 and Na,K-ATPase is facilitated by specific amino acids in the transmembrane domain of FXYD7, particularly two conserved glycine residues, Gly 29 and Gly 40. Mutations in these residues significantly reduce the association efficiency with Na,K-ATPase (Crambert2004FXYD7). The C-terminal valine residue of FXYD7 is also critical for its rapid export from the endoplasmic reticulum and subsequent association with Na,K-ATPase (Crambert2004FXYD7).

FXYD7's interaction with Na,K-ATPase does not affect the enzyme's affinity for intracellular Na+, indicating a specific modulatory role on the extracellular K+ binding sites (Geering2005Function). This interaction is thought to be physiologically relevant in the brain to ensure proper neuronal function and prevent excessive K+ undershoot (Geering2005Function).


## References


[1. (Crambert2004FXYD7) Gilles Crambert, Ciming Li, Lee Kim Swee, and Käthi Geering. Fxyd7, mapping of functional sites involved in endoplasmic reticulum export, association with and regulation of na,k-atpase. Journal of Biological Chemistry, 279(29):30888–30895, July 2004. URL: http://dx.doi.org/10.1074/JBC.M313494200, doi:10.1074/jbc.m313494200. This article has 52 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/JBC.M313494200)

[2. (Geering2005Function) Käthi Geering. Function of fxyd proteins, regulators of na, k-atpase. Journal of Bioenergetics and Biomembranes, 37(6):387–392, December 2005. URL: http://dx.doi.org/10.1007/s10863-005-9476-x, doi:10.1007/s10863-005-9476-x. This article has 87 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s10863-005-9476-x)

[3. (Garty2006ROLE) Haim Garty and Steven J.D. Karlish. Role of fxyd proteins in ion transport. Annual Review of Physiology, 68(1):431–459, January 2006. URL: http://dx.doi.org/10.1146/annurev.physiol.68.040104.131852, doi:10.1146/annurev.physiol.68.040104.131852. This article has 200 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1146/annurev.physiol.68.040104.131852)